Literature DB >> 2234711

Early amniocentesis: report of 407 cases with neonatal follow-up.

C A Penso1, M M Sandstrom, M F Garber, M Ladoulis, J M Stryker, B B Benacerraf.   

Abstract

Amniocentesis was performed for prenatal diagnosis in 407 pregnancies between the gestational ages of 11-14 weeks. The safety and accuracy of the procedure were compared with data obtained from collaborative studies of amniocentesis performed later in the second trimester. There were no differences observed with respect to accuracy, pseudomosaicism, or maternal-cell contamination related to the timing of the procedure. The fetal loss rate within 4 weeks of the procedure was 2.3%. Fetal losses appeared to be related to maternal complications such as bleeding and leakage of fluid that occurred within a day of the procedure. No major maternal complications were noted. Information regarding neonatal outcome, including pulmonary complications and congenital orthopedic postural deformities, was found to be similar to that in previous reports.

Entities:  

Mesh:

Year:  1990        PMID: 2234711

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Club foot, an adverse outcome of early amniocentesis: disruption or deformation? CEMAT. Canadian Early and Mid-Trimester Amniocentesis Trial.

Authors:  S A Farrell; A M Summers; L Dallaire; J Singer; J A Johnson; R D Wilson
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

2.  Fertility problems in males carrying an inversion of chromosome 10.

Authors:  Xinyue Zhang; Qingyang Shi; Yanhong Liu; Yuting Jiang; Xiao Yang; Ruizhi Liu; Hongguo Zhang
Journal:  Open Med (Wars)       Date:  2021-02-18

3.  Transabdominal embryofetoscopy for the detection of short rib-polydactyly syndrome, type II(Majewski), in the first trimester.

Authors:  Kook Lee; Jin Woo Lee; Doo Byung Chay; Sang Hee Lee; Si Hyun Cho; Bo Wook Kim; Ju Youn Hwang; Min Soo Park
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.